[go: up one dir, main page]

SI1051170T1 - Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration - Google Patents

Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration

Info

Publication number
SI1051170T1
SI1051170T1 SI9830038T SI9830038T SI1051170T1 SI 1051170 T1 SI1051170 T1 SI 1051170T1 SI 9830038 T SI9830038 T SI 9830038T SI 9830038 T SI9830038 T SI 9830038T SI 1051170 T1 SI1051170 T1 SI 1051170T1
Authority
SI
Slovenia
Prior art keywords
application
order
neural
substituted aminomethyl
promote
Prior art date
Application number
SI9830038T
Other languages
English (en)
Inventor
Thomas Fahrig
Irene Gerlach
Ervin Horvath
Reinhard Jork
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SI1051170T1 publication Critical patent/SI1051170T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
SI9830038T 1997-11-24 1998-11-11 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration SI1051170T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19751949A DE19751949A1 (de) 1997-11-24 1997-11-24 Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
PCT/EP1998/007197 WO1999026621A1 (fr) 1997-11-24 1998-11-11 Utilisation d'aminomethyl-chromanes pour empecher la degenerescence neuronale et favoriser la regeneration neuronale
EP98961174A EP1051170B1 (fr) 1997-11-24 1998-11-11 Utilisation d'aminomethyl-chromanes pour empecher la degenerescence neuronale et favoriser la regeneration neuronale

Publications (1)

Publication Number Publication Date
SI1051170T1 true SI1051170T1 (en) 2001-12-31

Family

ID=7849618

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830038T SI1051170T1 (en) 1997-11-24 1998-11-11 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration

Country Status (30)

Country Link
US (2) US6235774B1 (fr)
EP (1) EP1051170B1 (fr)
JP (1) JP2001523716A (fr)
KR (1) KR20010032357A (fr)
CN (1) CN1134256C (fr)
AR (1) AR016973A1 (fr)
AT (1) ATE206615T1 (fr)
AU (1) AU745759B2 (fr)
BG (1) BG64167B1 (fr)
CA (1) CA2311126A1 (fr)
DE (2) DE19751949A1 (fr)
DK (1) DK1051170T3 (fr)
ES (1) ES2164465T3 (fr)
HN (1) HN1998000169A (fr)
HU (1) HUP0004369A3 (fr)
IL (1) IL135904A (fr)
IS (1) IS5496A (fr)
MY (1) MY118414A (fr)
NO (1) NO20002638L (fr)
NZ (1) NZ504656A (fr)
PE (1) PE134999A1 (fr)
PL (1) PL340674A1 (fr)
PT (1) PT1051170E (fr)
RU (1) RU2217140C2 (fr)
SI (1) SI1051170T1 (fr)
SV (1) SV1998000138A (fr)
TR (1) TR200001471T2 (fr)
TW (1) TW524690B (fr)
WO (1) WO1999026621A1 (fr)
ZA (1) ZA9810668B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
CA2400637A1 (fr) * 2000-03-17 2001-09-27 Robert J. Collier, Jr. Composes a activite agoniste sur les recepteurs 5-ht2 et 5-ht1a destines au traitement du glaucome
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
SE0004455D0 (sv) * 2000-12-01 2000-12-01 Milos Pekny Method for neuron regeneration in the central nervous system
DE10101917A1 (de) * 2001-01-16 2002-07-18 Bayer Ag Verwendung von Chromanen
BR0211358A (pt) * 2001-07-26 2004-09-21 Merck Patent Gmbh Uso do composto de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-croman o e seus sais fisiologicamente aceitáveis
KR100886185B1 (ko) * 2001-09-12 2009-02-27 메르크 파텐트 게엠베하 운동 장애의 치료 및 추체외로 운동 장애의 치료를 위해 투여된 약물에 의해 유도된 부작용의 치료를 위한 치환된 아미노메틸 크로만의 신규한 용도
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
WO2005033092A1 (fr) * 2003-09-19 2005-04-14 Galileo Pharmaceuticals, Inc. Derives de chromane
DE102004017627A1 (de) * 2004-04-10 2005-10-27 Bayer Healthcare Ag Verwendung von vollen 5-HT1A-Agonisten zur Hemmung der opiat/opioid-induzierten Atemdepression
EP3490607A4 (fr) 2016-07-29 2020-04-08 Sunovion Pharmaceuticals Inc. Composés et compositions, et utilisations associées
CN116283877A (zh) 2016-07-29 2023-06-23 赛诺维信制药公司 化合物、组合物及其用途
RU2651756C1 (ru) * 2017-05-10 2018-04-23 Федеральное государственное бюджетное образовательное учреждение Высшего Образования Кубанский Государственный Медицинский Университет Министерства Здравоохранения Российской Федерации, КубГМУ Препарат для предотвращения образования глиальных рубцов
KR20200036008A (ko) * 2017-08-02 2020-04-06 선오비온 파마슈티컬스 인코포레이티드 이소크로만 화합물 및 이의 용도
CA3130849A1 (fr) 2019-03-14 2020-09-17 Sunovion Pharmaceuticals Inc. Sels d'un compose d'isochromanyle et formes cristallines, procedes de preparation, utilisations therapeutiques et compositions pharmaceutiques associees

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300523A (en) 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE19522088A1 (de) 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration

Also Published As

Publication number Publication date
TW524690B (en) 2003-03-21
TR200001471T2 (tr) 2000-10-23
HUP0004369A2 (hu) 2001-04-28
PL340674A1 (en) 2001-02-12
US20010018530A1 (en) 2001-08-30
ZA9810668B (en) 1999-05-26
SV1998000138A (es) 1999-05-25
HN1998000169A (es) 1999-11-03
KR20010032357A (ko) 2001-04-16
IS5496A (is) 2000-05-15
NO20002638D0 (no) 2000-05-23
DE19751949A1 (de) 1999-05-27
WO1999026621A1 (fr) 1999-06-03
AU745759B2 (en) 2002-03-28
US6235774B1 (en) 2001-05-22
JP2001523716A (ja) 2001-11-27
HUP0004369A3 (en) 2002-04-29
NO20002638L (no) 2000-05-23
AR016973A1 (es) 2001-08-01
BG104466A (en) 2001-02-28
US6331561B2 (en) 2001-12-18
CN1279604A (zh) 2001-01-10
ES2164465T3 (es) 2002-02-16
DK1051170T3 (da) 2001-12-27
CA2311126A1 (fr) 1999-06-03
IL135904A0 (en) 2001-05-20
PT1051170E (pt) 2002-02-28
IL135904A (en) 2003-07-06
BG64167B1 (bg) 2004-03-31
RU2217140C2 (ru) 2003-11-27
NZ504656A (en) 2002-02-01
ATE206615T1 (de) 2001-10-15
CN1134256C (zh) 2004-01-14
AU1668599A (en) 1999-06-15
PE134999A1 (es) 2000-03-05
EP1051170B1 (fr) 2001-10-10
MY118414A (en) 2004-10-30
DE59801724D1 (de) 2001-11-15
EP1051170A1 (fr) 2000-11-15

Similar Documents

Publication Publication Date Title
IL135904A0 (en) Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
PL335194A1 (en) Arylsulphonamides and their analogues as well as their application in treating neurodegenerative affections
PL341355A1 (en) Hydrocracking process selective in respect to middle fraction of distillate
GB2303321B (en) Improvements in and relating to grinding
GB2307937B (en) Improvements in and relating to security
GB9502584D0 (en) Improvements in and relating to wwarf removal
GB2322360B (en) Improvements in and relating to cartons
GB9702253D0 (en) Improvements in or relating to electrodes
GB9614365D0 (en) Improvements in and relating to hoardings
IL118120A0 (en) Methods of preventing neuron degeneration and promoting neuron regeneration
GB9802347D0 (en) Improvements in and relating to bioremediation
GB9718664D0 (en) Improvements in or relating to capsules
GB9707589D0 (en) Improvements in and relating to treatment
GB2298586B (en) Improvements in and relating to puzzles
GB9723767D0 (en) Improvements in and relating to seperation
GB9602806D0 (en) Improvements in and relating to jewellery
GB9725687D0 (en) Improvements in and relating to bioremediation
GB9510301D0 (en) Improvements in and relating to personal computers
GB9704906D0 (en) Improvements in and relating to hoisery
GB9707199D0 (en) Improvements in and relating to turnables
GB9711151D0 (en) Improvements in and relating to avalves
GB9712491D0 (en) Improvements in and relating to spring manufacture
GB9720171D0 (en) Improvements in and relating to doors
GB9504903D0 (en) Improvements in and relating to jewellery
GB9502707D0 (en) Improvements in and relating to jewellery